ATE427956T1 - Ckrox-peptide und ihre analoge zur behandlung von hautalterung - Google Patents

Ckrox-peptide und ihre analoge zur behandlung von hautalterung

Info

Publication number
ATE427956T1
ATE427956T1 AT05292121T AT05292121T ATE427956T1 AT E427956 T1 ATE427956 T1 AT E427956T1 AT 05292121 T AT05292121 T AT 05292121T AT 05292121 T AT05292121 T AT 05292121T AT E427956 T1 ATE427956 T1 AT E427956T1
Authority
AT
Austria
Prior art keywords
peptides
ckrox
analogues
treatment
skin aging
Prior art date
Application number
AT05292121T
Other languages
English (en)
Inventor
Thierry Oddos
Gaelle Bellemere
Original Assignee
Johnson & Johnson Consumer Fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Fr filed Critical Johnson & Johnson Consumer Fr
Application granted granted Critical
Publication of ATE427956T1 publication Critical patent/ATE427956T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05292121T 2005-10-11 2005-10-11 Ckrox-peptide und ihre analoge zur behandlung von hautalterung ATE427956T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05292121A EP1775306B1 (de) 2005-10-11 2005-10-11 ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung

Publications (1)

Publication Number Publication Date
ATE427956T1 true ATE427956T1 (de) 2009-04-15

Family

ID=35717506

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05292121T ATE427956T1 (de) 2005-10-11 2005-10-11 Ckrox-peptide und ihre analoge zur behandlung von hautalterung

Country Status (7)

Country Link
US (1) US20100093637A1 (de)
EP (1) EP1775306B1 (de)
JP (1) JP2009511520A (de)
AT (1) ATE427956T1 (de)
CA (1) CA2624990A1 (de)
DE (1) DE602005013788D1 (de)
WO (1) WO2007042254A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2349972B1 (es) 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
US8906432B2 (en) 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
KR20130099058A (ko) 2010-08-19 2013-09-05 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 파울로우닌 및/또는 파울로우니아 추출물을 포함하는 조성물 및 이의 용도
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9173913B2 (en) 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
KR101805690B1 (ko) * 2011-06-27 2018-01-10 (주)아모레퍼시픽 화장료 조성물을 포함하는 피부 미용 키트 및 도포방법
US9579278B2 (en) 2013-05-10 2017-02-28 Johnson & Johnson Consumer Inc. Compositions comprising extracts of Bursera simaruba
US20220098673A1 (en) 2019-01-24 2022-03-31 Council Of Scientific And Industrial Research Kit for detecting melanoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10508856A (ja) * 1994-11-15 1998-09-02 オスモティクス コーポレーション スキンケア組成物及びその適用方法
US6054143A (en) * 1998-03-24 2000-04-25 Jones; Alonzo H. Xylitol delivery
AU2001263155A1 (en) * 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
DE10100121A1 (de) * 2001-01-03 2002-08-01 Henkel Kgaa Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro
ATE510852T1 (de) 2001-10-30 2011-06-15 Dsm Ip Assets Bv Dermopharmazeutisch und kosmetisch wirksame oligopeptide

Also Published As

Publication number Publication date
EP1775306A1 (de) 2007-04-18
DE602005013788D1 (de) 2009-05-20
CA2624990A1 (en) 2007-04-19
JP2009511520A (ja) 2009-03-19
WO2007042254A1 (en) 2007-04-19
US20100093637A1 (en) 2010-04-15
EP1775306B1 (de) 2009-04-08

Similar Documents

Publication Publication Date Title
DE60335997D1 (de) Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
DE602004022061D1 (de) Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen
ATE520391T1 (de) Verwendung von einem phaeodactylum-algen-extrakt zur förderung der hautzellen-proteasom-aktivität
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE427956T1 (de) Ckrox-peptide und ihre analoge zur behandlung von hautalterung
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
ATE534379T1 (de) Neue verwendung von peptid-verbindungen zur behandlung von muskelschmerzen
ATE481978T1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
EP1469810A4 (de) Zusammensetzungen und verfahren zur verhütung und behandlung von erkrankungen im zusammenhang mit amyloid-beta peptid
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE492542T1 (de) Herstellung und anwendung von biphenyl-4-yl- carbonylaminosäurederivaten zur behandlung von obesitas
DE60328517D1 (de) Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung
DE69911210D1 (de) Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs
DE602005004139D1 (de) Verwendung von Salicyloyl-Sphingoidbase zur Behandlung oder Verhinderung von Cellilitis
WO2009125925A3 (ko) 성장인자―미미킹 펩타이드 및 그의 용도
ATE428413T1 (de) Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
ATE471717T1 (de) Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
DE602006020898D1 (de) Peptide zur förderung des haarwachstums und zur verbesserung von falten und kosmetische zusammensetzungen, die diese enthalten
WO2006113681A3 (en) Plant-derived elastin binding protein ligands and methods of using the same
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
DE60335647D1 (de) Pyrroloquinoline quinone und ein betablocker zur behandlung von ischämie oder reperfusionsschäden
ATE473728T1 (de) Verwendung von fluoreszierenden perlylenverbindungen zur behandlung menschlicher haare
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
ATE457736T1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
DE60327856D1 (de) Zusammensetzungen und verfahren zur hautbräunung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties